Cocrystal Pharma, Inc.(COCP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

COCP Cocrystal Pharma, Inc.

交易中 09-29 11:29:37 EDT

1.16

-0.05

-4.13%

最高1.24	最低1.15	成交量7.60万
今开1.24	昨收1.21	日振幅7.85%
总市值2,235万	流通市值1,374万	总股本1,926万
成交额9.00万	换手率0.64%	流通股本1,185万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"COCP","market":"US","secType":"STK","nameCN":"Cocrystal Pharma, Inc.","latestPrice":1.16,"timestamp":1790695640643,"preClose":1.21,"halted":0,"volume":76033,"delay":0,"changeRate":-0.04132231404958681,"floatShares":11848100,"shares":19263200,"eps":-0.761346,"marketStatus":"交易中","change":-0.05,"latestTime":"09-29 11:29:37 EDT","open":1.24,"high":1.24,"low":1.145,"amount":90009.01349829999,"amplitude":0.078512,"askPrice":1.16,"askSize":74,"bidPrice":1.15,"bidSize":646,"shortable":3,"etf":0,"ttmEps":-0.761346,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790712000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.21,"preHourTrading":{"tag":"盘前","latestPrice":1.23,"preClose":1.21,"latestTime":"09:28 EDT","volume":131,"amount":154.5000114,"timestamp":1790688504077,"change":0.02,"changeRate":0.016529,"amplitude":0.173554},"postHourTrading":{"tag":"盘后","latestPrice":1.21,"preClose":1.21,"latestTime":"16:10 EDT","volume":6,"amount":7.26,"timestamp":1790626204325,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":6.550295},"requestUrl":"/m/hq/s/COCP/tweets","defaultTab":"tweets","newsList":[{"id":"1190774976","title":"Cocrystal Pharma宣布CDI-988治疗诺如病毒1B期人体挑战试验完成全部受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1190774976","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190774976?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:01","pubTimestamp":1788951670,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma, Inc.今日宣布，其评估CDI-988用于诺如病毒预防与治疗的1B期人体挑战试验，已完成最后一名受试者的给药。此举标志着该临床试验进入关键节点，为这一候选抗病毒药物的后续数据读出奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169942899","title":"Cocrystal Pharma任命James Sapirstein为新任首席执行官 后者为拥有丰富抗病毒药物开发经验的生物制药行业领袖","url":"https://stock-news.laohu8.com/highlight/detail?id=1169942899","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169942899?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:06","pubTimestamp":1780484801,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma, Inc. 已正式任命James Sapirstein为公司首席执行官。Sapirstein先生是一位在生物制药行业备受尊敬的领袖，尤其在抗病毒药物开发领域拥有极为深厚的经验。他的加入预计将为公司的战略发展带来新的动力和方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116663232","title":"Cocrystal Pharma宣布发现靶向汉坦病毒、布尼亚病毒及流感的广谱抗病毒抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1116663232","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116663232?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:33","pubTimestamp":1779798796,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma, Inc. 通过一份提交给美国证券交易委员会（SEC）的文件宣布，其研究团队已成功发现一类新型广谱抗病毒抑制剂。该抑制剂展现出针对多种重要病毒的潜在活性，包括汉坦病毒、布尼亚病毒以及流感病毒。\n这一发现标志着公司在抗病毒药物研发领域取得了重要进展。所发现的抑制剂旨在靶向病毒生命周期中的关键且保守的环节，从而可能对多种相关病毒株产生抑制作用，具备成为“泛病毒”疗法的潜力。\n公司表示，相关发现是基于其专有的药物发现平台技术取得的。下一步，Cocrystal计划推进这些先导化合物的临床前开发工作，以进一步评估其安全性和有效性，为未来可能的临床研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163319787","title":"Cocrystal Pharma旗下Cdi-988获FDA快速通道资格，用于诺如病毒感染治疗与预防","url":"https://stock-news.laohu8.com/highlight/detail?id=1163319787","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163319787?lang=zh_cn&edition=full","pubTime":"2026-04-02 20:02","pubTimestamp":1775131344,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma, Inc.宣布，其研发的抗病毒候选药物Cdi-988已获得美国食品药品监督管理局（FDA）授予的快速通道资格。该资格旨在加速Cdi-988针对诺如病毒感染的治疗及预防用途的开发和审评进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136829903","title":"Cocrystal Pharma公布2025年财务业绩并更新抗病毒药物研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1136829903","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136829903?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:01","pubTimestamp":1774958487,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma, Inc.近日披露了其2025财年的财务报告，并同步通报了公司在抗病毒药物研发项目上的最新进展。作为一家专注于开发创新抗病毒疗法的生物制药公司，Cocrystal Pharma持续投入研发，旨在应对全球范围内严峻的病毒感染挑战。财务数据显示，公司在2025财年保持了稳健的财务状况，为后续的临床研究和管线推进提供了有力支撑。未来，Cocrystal Pharma计划通过战略合作与内部研发双轮驱动，持续拓展其抗病毒产品组合，为未满足的医疗需求提供创新解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518727929","title":"Cocrystal Pharma, Inc.盘中异动 早盘股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518727929?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:12","pubTimestamp":1741619541,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时12分，Cocrystal Pharma, Inc.股票出现波动，股价快速拉升5.82%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3569.34%、955.28%、797.28%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023122198a2b529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023122198a2b529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516932663","title":"Cocrystal Pharma, Inc.盘中异动 临近收盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516932663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516932663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:43","pubTimestamp":1741034585,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时43分，Cocrystal Pharma, Inc.股票出现异动，股价急速上涨5.20%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044305abe69a06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044305abe69a06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331981","title":"Cocrystal Pharma, Inc.盘中异动 下午盘急速拉升6.32%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331981?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:12","pubTimestamp":1740683553,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时12分，Cocrystal Pharma, Inc.股票出现异动，股价急速上涨6.32%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280312339632e543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280312339632e543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514159800","title":"Cocrystal Pharma, Inc.盘中异动 早盘股价大跌5.49%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514159800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514159800?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:26","pubTimestamp":1740497187,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时26分，Cocrystal Pharma, Inc.股票出现异动，股价大幅跳水5.49%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523262798925919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523262798925919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727311","title":"Cocrystal Pharma, Inc.盘中异动 早盘快速下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513727311?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407528,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Cocrystal Pharma, Inc.股票出现波动，股价大幅跳水5.13%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223208abdb0dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223208abdb0dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513297048","title":"Cocrystal Pharma, Inc.盘中异动 大幅拉升6.12%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513297048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513297048?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:47","pubTimestamp":1740156424,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时47分，Cocrystal Pharma, Inc.股票出现波动，股价大幅上涨6.12%。截至发稿，该股报2.08美元/股，成交量1.0063万股，换手率0.10%，振幅4.85%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222004704962b99a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222004704962b99a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512360114","title":"Cocrystal Pharma, Inc.盘中异动 股价大涨6.52%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512360114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512360114?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:47","pubTimestamp":1739994427,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时47分，Cocrystal Pharma, Inc.股票出现异动，股价急速上涨6.52%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220034707abd536bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220034707abd536bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511268395","title":"Cocrystal Pharma, Inc.盘中异动 股价大跌8.85%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511268395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511268395?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:39","pubTimestamp":1739457577,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时39分，Cocrystal Pharma, Inc.股票出现异动，股价大幅下挫8.85%。截至发稿，该股报1.75美元/股，成交量1025股，换手率0.01%，振幅4.17%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132239379621bdfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132239379621bdfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333194","title":"Cocrystal Pharma, Inc.盘中异动 早盘股价大跌5.70%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510333194?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:20","pubTimestamp":1739287211,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时20分，Cocrystal Pharma, Inc.股票出现异动，股价大幅下挫5.70%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.59%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232012abcb1104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232012abcb1104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865083","title":"Cocrystal Pharma, Inc.盘中异动 股价大涨6.01%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510865083?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:37","pubTimestamp":1739198228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时37分，Cocrystal Pharma, Inc.股票出现异动，股价快速拉升6.01%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223708abc9a6c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223708abc9a6c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509979491","title":"Cocrystal Pharma, Inc.盘中异动 临近收盘快速上涨5.35%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509979491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509979491?lang=zh_cn&edition=full","pubTime":"2025-02-05 05:01","pubTimestamp":1738702910,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日05时01分，Cocrystal Pharma, Inc.股票出现波动，股价大幅上涨5.35%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205050151987a8603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205050151987a8603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508537173","title":"Cocrystal Pharma, Inc.盘中异动 股价大跌6.03%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508537173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508537173?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:56","pubTimestamp":1738616171,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时56分，Cocrystal Pharma, Inc.股票出现波动，股价急速下跌6.03%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Invivyd, Inc.、Hcw Biologics Inc.、Gh Research Plc涨幅较大，Cyclerion Therapeutics, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为1070.19%、765.15%、480.04%，振幅较大的相关个股有Invivyd, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.，振幅分别为188.15%、174.91%、63.94%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502040456119879a2df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502040456119879a2df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506588718","title":"Cocrystal Pharma, Inc.盘中异动 急速下跌5.03%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506588718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506588718?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:55","pubTimestamp":1738000539,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时55分，Cocrystal Pharma, Inc.股票出现异动，股价快速下挫5.03%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2120.63%、935.50%、253.81%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、85.35%、65.16%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128015539a2319364&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128015539a2319364&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505770324","title":"Cocrystal Pharma, Inc.盘中异动 股价大涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505770324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505770324?lang=zh_cn&edition=full","pubTime":"2025-01-23 03:43","pubTimestamp":1737574980,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时43分，Cocrystal Pharma, Inc.股票出现异动，股价急速拉升5.76%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123034300a22bf1eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123034300a22bf1eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505272923","title":"Cocrystal Pharma, Inc.盘中异动 早盘股价大涨6.24%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505272923?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:44","pubTimestamp":1737470686,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时44分，Cocrystal Pharma, Inc.股票出现异动，股价快速拉升6.24%。截至发稿，该股报2.10美元/股，成交量3634股，换手率0.04%，振幅106.24%。Cocrystal Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Cocrystal Pharma, Inc.公司简介：Cocrystal Pharma Inc 是一家生物技术公司，致力于发现和开发针对流感病毒，丙型肝炎病毒和诺罗病毒复制机制的新型抗病毒疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224446abb34a58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224446abb34a58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cocrystalpharma.com","stockEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":0.1},{"period":"3month","weight":0.1524},{"period":"6month","weight":0.1863},{"period":"1year","weight":-0.032},{"period":"ytd","weight":0.236}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.0252},{"period":"6month","weight":0.1684},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1227}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cocrystal Pharma, Inc.于2014年1月2日在特拉华州注册成立。其主要业务是开发用于治疗人类病毒性疾病的新药。 Cocrystal Pharma，Inc.自2008年投入资金以来，一直致力于开发新型技术和方法，以创造一流的同类最佳抗病毒药物。该公司的重点是追求开发和商业化的广谱抗病毒药物候选物，将改变人类病毒性疾病的治疗和预防。该公司计划利用他们在这些领域的基础设施和专业知识，将研究和开发工作集中在病毒复制抑制剂上。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.070056},{"month":2,"riseRate":0.25,"avgChangeRate":0.064327},{"month":3,"riseRate":0.25,"avgChangeRate":-0.104016},{"month":4,"riseRate":0.555556,"avgChangeRate":0.017178},{"month":5,"riseRate":0.444444,"avgChangeRate":0.006297},{"month":6,"riseRate":0.777778,"avgChangeRate":0.141344},{"month":7,"riseRate":0.444444,"avgChangeRate":0.000075},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.013326},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.161255},{"month":10,"riseRate":0.125,"avgChangeRate":-0.206494},{"month":11,"riseRate":0.75,"avgChangeRate":0.316208},{"month":12,"riseRate":0.125,"avgChangeRate":-0.139649}],"exchange":"NASDAQ","name":"Cocrystal Pharma, Inc.","nameEN":"Cocrystal Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cocrystal Pharma, Inc.(COCP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cocrystal Pharma, Inc.(COCP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cocrystal Pharma, Inc.,COCP,Cocrystal Pharma, Inc.股票,Cocrystal Pharma, Inc.股票老虎,Cocrystal Pharma, Inc.股票老虎国际,Cocrystal Pharma, Inc.行情,Cocrystal Pharma, Inc.股票行情,Cocrystal Pharma, Inc.股价,Cocrystal Pharma, Inc.股市,Cocrystal Pharma, Inc.股票价格,Cocrystal Pharma, Inc.股票交易,Cocrystal Pharma, Inc.股票购买,Cocrystal Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cocrystal Pharma, Inc.(COCP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cocrystal Pharma, Inc.(COCP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}